Characterization of antibodies to the insulin receptor: a cause of insulin-resistant diabetes in man.
AUTOR(ES)
Flier, J S
RESUMO
We have characterized the circulating inhibitor of insulin receptor binding found in several patients with a new syndrome of extreme insulin resistance. The inhibitor is an immunoglobulin by multiple criteria, including precipitation by 33% ammonium sulfate, migration on G-200 Sephadex gel filtration and DEAE chromatography, and immuno-precipitation with specific anti-human immuno-globulins. Although predominantly IgG, some activity is found in the IgM fraction of the immunoglobulins in one patient. The inhibitory immunoglobulins reacted with antisera to both kappa and lambda light chain determinants and are therefore polyclonal. In addition, activity is retained in the F(ab')2 fraction of pepsin-digested IgG. Evidence suggests that these antibodies are directed at determinants on or near the insulin receptor, and that they are responsible for the observed clinical insulin resistance.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=333316Documentos Relacionados
- A mutation in the insulin receptor gene that impairs transport of the receptor to the plasma membrane and causes insulin-resistant diabetes.
- Insulin receptor biosynthesis in cultured lymphocytes from insulin-resistant patients.
- INSULIN-RESISTANT DIABETES ASSOCIATED WITH INCREASED ENDOGENOUS PLASMA INSULIN FOLLOWED BY COMPLETE REMISSION
- Defective insulin response of phosphorylase phosphatase in insulin-resistant humans.
- Severe insulin-resistant diabetes mellitus in patients with congenital muscle fiber type disproportion myopathy.